Literature DB >> 8522336

No evidence of genetic heterogeneity in Crouzon craniofacial dysostosis.

H W Ma1, E Lajeunie, M Le Merrer, N de Parseval, F Serville, J Weissenbach, A Munnich, D Renier.   

Abstract

Crouzon craniofacial dysostosis (CFD) is an autosomal dominant form of craniosynostosis characterized by an abnormal skull shape, with hypertelorism, prominent eyes and midfacial retrusion. Recently, a gene for CFD has been mapped to chromosome 10q25-q26 and mutations in exon B of the fibroblast growth factor receptor 2 (FGFR2) gene have been identified. Here, we report the mapping of a CFD gene to chromosome 10q by close linkage to probe AFMa197wb1 at locus D10 S1483 in six unrelated families of French ancestry (Zmax = 4.69 at theta = 0) and provide additional evidence of genetic homogeneity of this condition. In addition, we report a novel mutation in exon B of the FGFR2 gene (Cys 342 Trp) in familial CFD and describe recurrent mutations at codon 342 as a particularly frequent event in CFD. Since mutations in the extracellular domain of the FGFR2 gene are observed in a few clinically distinct craniosynostosis syndromes (CFD, Jackson-Weiss, Apert and Pfeiffer), the present study gives support to the variable clinical expression of FGFR2 mutations in humans.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8522336     DOI: 10.1007/bf00210308

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  9 in total

1.  FGFR2 mutations in Pfeiffer syndrome.

Authors:  E Lajeunie; H W Ma; J Bonaventure; A Munnich; M Le Merrer; D Renier
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

2.  A gene for Crouzon craniofacial dysostosis maps to the long arm of chromosome 10.

Authors:  R A Preston; J C Post; B J Keats; C E Aston; R E Ferrell; J Priest; N Nouri; H W Losken; C A Morris; M R Hurtt
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

3.  A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome.

Authors:  M Muenke; U Schell; A Hehr; N H Robin; H W Losken; A Schinzel; L J Pulleyn; P Rutland; W Reardon; S Malcolm
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

4.  Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2.

Authors:  E W Jabs; X Li; A F Scott; G Meyers; W Chen; M Eccles; J I Mao; L R Charnas; C E Jackson; M Jaye
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

5.  Two craniosynostotic syndrome loci, Crouzon and Jackson-Weiss, map to chromosome 10q23-q26.

Authors:  X Li; A F Lewanda; F Eluma; H Jerald; H Choi; I Alozie; C Proukakis; C C Talbot; C Vander Kolk; L M Bird
Journal:  Genomics       Date:  1994-07-15       Impact factor: 5.736

6.  Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome.

Authors:  A O Wilkie; S F Slaney; M Oldridge; M D Poole; G J Ashworth; A D Hockley; R D Hayward; D J David; L J Pulleyn; P Rutland
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

7.  Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia.

Authors:  R Shiang; L M Thompson; Y Z Zhu; D M Church; T J Fielder; M Bocian; S T Winokur; J J Wasmuth
Journal:  Cell       Date:  1994-07-29       Impact factor: 41.582

8.  Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome.

Authors:  W Reardon; R M Winter; P Rutland; L J Pulleyn; B M Jones; S Malcolm
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

9.  Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia.

Authors:  F Rousseau; J Bonaventure; L Legeai-Mallet; A Pelet; J M Rozet; P Maroteaux; M Le Merrer; A Munnich
Journal:  Nature       Date:  1994-09-15       Impact factor: 49.962

  9 in total
  5 in total

1.  Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome.

Authors:  S F Slaney; M Oldridge; J A Hurst; G M Moriss-Kay; C M Hall; M D Poole; A O Wilkie
Journal:  Am J Hum Genet       Date:  1996-05       Impact factor: 11.025

2.  A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome.

Authors:  M Muenke; K W Gripp; D M McDonald-McGinn; K Gaudenz; L A Whitaker; S P Bartlett; R I Markowitz; N H Robin; N Nwokoro; J J Mulvihill; H W Losken; J B Mulliken; A E Guttmacher; R S Wilroy; L A Clarke; G Hollway; L C Adès; E A Haan; J C Mulley; M M Cohen; G A Bellus; C A Francomano; D M Moloney; S A Wall; A O Wilkie
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

3.  FGFR2 mutation in a Chinese family with unusual Crouzon syndrome.

Authors:  Zi-Li Li; Xue Chen; Wen-Juan Zhuang; Wei Zhao; Ya-Ni Liu; Fang-Xia Zhang; Ruo-Shui Ha; Jin-Hua Wu; Chen Zhao; Xun-Lun Sheng
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

4.  Crouzon syndrome in a fraternal twin: A case report and review of the literature.

Authors:  Xiao-Jing Li; Ji-Mei Su; Xiao-Wei Ye
Journal:  World J Clin Cases       Date:  2022-06-06       Impact factor: 1.534

Review 5.  Understanding craniosynostosis as a growth disorder.

Authors:  Kevin Flaherty; Nandini Singh; Joan T Richtsmeier
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2016-03-22       Impact factor: 5.814

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.